11-108256340-G-C

Variant summary

Our verdict is Uncertain significance.
+4 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 4 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO5_SupportingO6_Supporting

The NM_000051.4(ATM):c.2250G>C (p.Lys750Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The gene ATM is a tumor suppressor gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a known oncogene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The gene ATM is a cancer driver gene (CancerMine: 26 TSG, 31 oncogene, 24 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. Variant has been reported in ClinVar as Uncertain Significance (★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.K750R: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1788378) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.K750E: Uncertain_significance (ClinVar VariationId 919060, 2 stars); p.K750N: Uncertain_significance (ClinVar VariationId 3911965, 1 star); p.K750T: Uncertain_significance (ClinVar VariationId 407469, 2 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: not found (cov: 32)

Consequence

ATM
NM_000051.4 missense, splice_region

Scores

5
8
6
Splicing: ADA: 1.000
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.70

Publications

19 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Natera, Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, G2P, Orphanet, Natera, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000051.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 4 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O5Same location/impact as known oncogenic
Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); Beware: this change may impact splicing rather than at the amino acid/protein level; ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer does not indicate an oncogenic effect; O6 not met via missense path; Splice-region variant — splicing algorithms predict an impact on splicing; supports O6

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ATM NM_000051.4
MANE Select
HGVSc / HGVSpc.2250G>Cp.Lys750Asn
Exon rankExon 14 of 63
missensesplice_region
Prot: NP_000042.3
ATM NM_001351834.2
HGVSc / HGVSpc.2250G>Cp.Lys750Asn
Exon rankExon 15 of 64
missensesplice_region
Prot: NP_001338763.1UniProt: Q13315

Ensembl Transcripts

ATM ENST00000675843.1
MANE Select
HGVSc / HGVSpc.2250G>Cp.Lys750Asn
Exon rankExon 14 of 63
missensesplice_region
Prot: ENSP00000501606.1UniProt: Q13315
ATM ENST00000452508.7
TSL:1
HGVSc / HGVSpc.2250G>Cp.Lys750Asn
Exon rankExon 15 of 64
missensesplice_region
Prot: ENSP00000388058.2UniProt: Q13315
ATM ENST00000531525.3
TSL:1
HGVSc / HGVSpc.2250G>Cp.Lys750Asn
Exon rankExon 14 of 30
missensesplice_region
Prot: ENSP00000434327.3UniProt: H0YDU7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:30
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Ataxia-telangiectasia syndrome (1)

Computational Scores

AlphaGenome AVI
Pathogenic42
AlphaMissense
Pathogenic0.84
BayesDel_addAF
Benign-0.0048T
BayesDel_noAF
Benign-0.24
CADD
Pathogenic29
DANN
Uncertain1.0
DEOGEN2
Benign0.13T
Eigen
Pathogenic0.71
Eigen_PC
Pathogenic0.68
FATHMM_MKL
Pathogenic0.98D
FuncVEP CTI
Benign0.055
GPN-Star LLR
N/A-8.4
GPN-Star score
N/A8.4
LIST_S2
Benign0.81T
M_CAP
Uncertain0.19D
MetaRNN
Uncertain0.44T
MetaSVM
Uncertain0.17D
Mutation Taster
N/A6/94disease causing
MutationAssessor
Uncertain2.8M
PhyloP100
Uncertain4.7
PrimateAI
Uncertain0.52T
PROVEAN
Benign-2.1N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A2.9
REVEL
Uncertain0.31
Sift
Uncertain0.0080D
Sift4G
Pathogenic0.0D
Varity_R
N/A0.74
VESM-3B
Benign-5.6
Showing 29 of 29 scores

Splicing Scores

dbscSNV1_ADA
Pathogenic1.0
dbscSNV1_RF
Pathogenic1.0
DS_DL_spliceai
Pathogenic0.98
Position offset: 0
Pangolin (max)
Pathogenic0.85
Pangolin loss
Pathogenic0.85
Position offset: 0
SpliceAI score (max)
Pathogenic0.98
Details are displayed if max score is > 0.2
Showing 6 of 6 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.